Springer Pancreatic Cancer (MD Anderson Solid Tumor Oncology Series)

The MD Anderson Solid Tumor Oncology series presents cutting-edge surgical treatment and medical therapy for specific sites. This volume, Pancreatic Cancer, addresses epidemiology and molecular biology, inherited syndromes, staging, surgical techniques, multimodality therapy, and emerging therapies. The individual chapters focus on narrow, specific topics to produce a reference work of value to those interested in pancreatic cancer from a clinical and translational research perspective. A must-have for surgical oncologists and general surgeons. Review From the reviews: "This volume about pancreatic cancer defines the standard on multimodality care … . All chapters of this volume are written by outstanding authors who are among the leading world experts, and it is completed by several tables and high-quality images … . At a time when research is beginning to understand the molecular basis of solid tumours, this volume becomes a precious tool … . It is almost mandatory for clinicians, surgical oncologists and general surgeons to have such an in-depth, up-to-date and referenced volume." (C. Cucino, Digestive and Liver Disease, Vol. 36, 2004) "This monograph covers all current aspects of the management of pancreatic cancer in commendable detail. The book is well produced and contains sufficient illustrations in high quality black and white. … There is considerable attention to detail of the technique for surgical resection, and one chapter each has been devoted to endoscopic palliation and celiac plexus block. … this book provides a comprehensive review of pancreatic cancer, with well-referenced reviews in the majority of areas of current therapeutic interest ." (Colin D. Johnson, European Journal of Cancer Care, Vol. 12 (3), 2003) "Pancreatic Cancer, which is part of the MD Anderson Solid Tumour Oncology Series, is an extremely worthwhile reference book for clinicians involved in the management of pancreatic cancer. … pancreatic cancer poses a difficult management problem for clinicians. An understanding of tumour biology by clinicians will assist with the introduction of … new therapies into clinical practice. This book will undoubtedly achieve its intended aim." (D. Fenton-Lee, Cancer Forum, Vol. 27 (1), 2003) "The purpose of this book is to provide information to anyone interested in the field of pancreatic cancer, in order to achieve the best care for patients … . The strength of this book is represented by the last part, which provides up-to-date and novel insights on emerging therapies of pancreatic cancer. … this is a valuable book. It will give clinicians involved in this particular field an excellent background and introduction, plus a clear view on future development." (S. Cascinu, Annals of Oncology, Vol. 13 (6), 2002)